Profiel
Ms. Hema Keshava is a Senior Vice President-Finance at Abivax SA and a Corporate Controller at CinCor Pharma, Inc.
Actieve functies van Hema Keshava
| Bedrijven | Functie | Begin |
|---|---|---|
| CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 01-11-2021 |
| ABIVAX | Corporate Officer/Principal | 01-07-2023 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABIVAX | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
